Venture
Vizgen, Inc.
Latest Form D 2026-01-12- CIK 1790415
- State MA
- Biotechnology
- 6 Form D offerings since 2019-10-15
- Total sold
- $295M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2019-10-15
- Latest round
- $47.8M
- 2026-01-12 · 021-569582
- Investors
- 9
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-01-12 · $47.8M
- 2019-10-15$14M021-350965
- 2021-04-08$37M021-395106
- 2022-05-05$85.2M021-444596
- 2024-10-22$108M021-527442
- 2025-10-07$3.5M021-560062
- 2026-01-12$47.8M021-569582
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($108M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-569582 | First filed2026-01-12 | Latest2026-01-12 | Sought$50M | Sold$47.8M | Investors9 | Exemptions506(b) |
| 021-560062 | First filed2025-10-07 | Latest2025-10-07 | Sought$9.5M | Sold$3.5M | Investors7 | Exemptions506(b) |
| 021-527442 | First filed2024-10-22 | Latest2024-10-22 | SoughtIndefinite | Sold$108M | Investors61 | Exemptions506(b) |
| 021-444596 | First filed2022-05-05 | Latest2022-05-05 | Sought$105M | Sold$85.2M | Investors15 | Exemptions506(b) |
| 021-395106 | First filed2021-04-08 | Latest2021-04-08 | Sought$37M | Sold$37M | Investors12 | Exemptions506(b) |
| 021-350965 | First filed2019-10-15 | Latest2019-10-15 | Sought$14M | Sold$14M | Investors3 | Exemptions506(b) |
Who backs Vizgen, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-01-12
| Name | Relationship |
|---|---|
| Robert Carson | RelationshipExecutive Officer, Director |
| Simona Levi | RelationshipExecutive Officer |
| Matthew Posard | RelationshipDirector |
| Keith Crandell | RelationshipDirector |
| Andrea Jackson | RelationshipDirector |
| David Walt | RelationshipDirector |
| Christian Uhrich | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b)
- First filed
- 2019-10-15
- Latest filing
- 2026-01-12
Who backs Vizgen, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗